FTH1 and COVID-19: Likewise, human endothelial cells treated with serum from COVID-19 non-survivors show increased ROS, elevated MDA/4-HNE, decreased GPX4, SLC7A11 and FTH1, all of which are reversible by Fer-1 or by blocking TNFR1 signalling [207].